Literature DB >> 32622346

Effect of Lower Blood Pressure Goals on Left Ventricular Structure and Function in Patients With Subclinical Hypertensive Heart Disease.

Phillip D Levy1,2, Michael J Burla3, Michael J Twiner1,2, Alexander L Marinica4, James J Mahn5, Brian Reed1,2, Aaron Brody1,2, Robert Ehrman1, Allie Brodsky1,2, Yiying Zhang2,6, Samar A Nasser7, John M Flack8.   

Abstract

BACKGROUND: Subclinical hypertensive heart disease (SHHD) is a precursor to heart failure. Blood pressure (BP) reduction is an important component of secondary disease prevention in patients with SHHD. Treating patients with SHHD utilizing a more intensive BP target (120/80 mm Hg), may lead to improved cardiac function but there has been limited study of this, particularly in African Americans (AAs).
METHODS: We conducted a single center, randomized controlled trial where subjects with uncontrolled, asymptomatic hypertension, and SHHD not managed by a primary care physician were randomized to standard (<140/90 mm Hg) or intensive (<120/80 mm Hg) BP therapy groups with quarterly follow-up for 12 months. The primary outcome was the differences of BP reduction between these 2 groups and the secondary outcome was the improvement in echocardiographic measures at 12 months.
RESULTS: Patients (95% AAs, 65% male, mean age 49.4) were randomized to the standard (n = 65) or the intensive (n = 58) BP therapy groups. Despite significant reductions in systolic BP (sBP) from baseline (-10.9 vs. -19.1 mm Hg, respectively) (P < 0.05), no significant differences were noted between intention-to-treat groups (P = 0.33) or the proportion with resolution of SHHD (P = 0.31). However, on post hoc analysis, achievement of a sBP <130 mm Hg was associated with significant reduction in indexed left ventricular mass (-6.91 gm/m2.7; P = 0.008) which remained significant on mixed effect modeling (P = 0.031).
CONCLUSIONS: In post hoc analysis, sBP <130 mm Hg in predominantly AA patients with SHHD was associated with improved cardiac function and reverse remodeling and may help to explain preventative effects of lower BP goals. CLINICAL TRIALS REGISTRATION: Trial Number NCT00689819. © American Journal of Hypertension, Ltd 2020. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  African American; blood pressure; heart failure; hypertension; left ventricular hypertrophy; subclinical hypertensive heart disease; urban

Year:  2020        PMID: 32622346      PMCID: PMC7481985          DOI: 10.1093/ajh/hpaa108

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  40 in total

1.  Racial differences in blood pressure control: potential explanatory factors.

Authors:  Hayden B Bosworth; Tara Dudley; Maren K Olsen; Corrine I Voils; Benjamin Powers; Mary K Goldstein; Eugene Z Oddone
Journal:  Am J Med       Date:  2006-01       Impact factor: 4.965

2.  Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study.

Authors:  M S Lauer; K M Anderson; D Levy
Journal:  J Am Coll Cardiol       Date:  1992-01       Impact factor: 24.094

3.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

Authors:  Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

4.  Tissue Doppler E/E' ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy.

Authors:  Andrew S P Sharp; Robyn J Tapp; Simon A McG Thom; Darrel P Francis; Alun D Hughes; Alice V Stanton; Andrew Zambanini; Eoin O'Brien; Nish Chaturvedi; Simon Lyons; Sheila Byrd; Neil R Poulter; Peter S Sever; Jamil Mayet
Journal:  Eur Heart J       Date:  2009-11-26       Impact factor: 29.983

5.  Blood pressure control determines improvement in diastolic dysfunction in early hypertension.

Authors:  Ibrahim Almuntaser; Azra Mahmud; Angie Brown; Ross Murphy; Gerard King; Peter Crean; John Feely
Journal:  Am J Hypertens       Date:  2009-09-17       Impact factor: 2.689

6.  Blood pressure control and perceived health status in African Americans with subclinical hypertensive heart disease.

Authors:  Michael J Burla; Aaron M Brody; Brian A Ference; John M Flack; James J Mahn; Alexander L Marinica; Justin A Carroll; Samar A Nasser; Shiling Zhang; Phillip D Levy
Journal:  J Am Soc Hypertens       Date:  2014-02-25

7.  Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.

Authors:  Barbara V Howard; Mary J Roman; Richard B Devereux; Jerome L Fleg; James M Galloway; Jeffrey A Henderson; Wm James Howard; Elisa T Lee; Mihriye Mete; Bryce Poolaw; Robert E Ratner; Marie Russell; Angela Silverman; Mario Stylianou; Jason G Umans; Wenyu Wang; Matthew R Weir; Neil J Weissman; Charlton Wilson; Fawn Yeh; Jianhui Zhu
Journal:  JAMA       Date:  2008-04-09       Impact factor: 56.272

8.  Racial differences in the outcomes of patients with diastolic heart failure.

Authors:  Mark A East; Eric D Peterson; Linda K Shaw; Wendy A Gattis; Christopher M O'Connor
Journal:  Am Heart J       Date:  2004-07       Impact factor: 4.749

9.  Racial disparity in hypertension control: tallying the death toll.

Authors:  Kevin Fiscella; Kathleen Holt
Journal:  Ann Fam Med       Date:  2008 Nov-Dec       Impact factor: 5.166

10.  Changing trends in the prevalence and disparities of obesity and other cardiovascular disease risk factors in three racial/ethnic groups of USA adults.

Authors:  Camila X Romero; Tomas E Romero; Judith C Shlay; Lorraine G Ogden; Dana Dabelea
Journal:  Adv Prev Med       Date:  2012-12-02
View more
  2 in total

1.  Global, regional, and national burden of hypertensive heart disease during 1990-2019: an analysis of the global burden of disease study 2019.

Authors:  Yunyan Lu; Tian Lan
Journal:  BMC Public Health       Date:  2022-04-27       Impact factor: 4.135

Review 2.  Targets and management of hypertension in heart failure: focusing on the stages of heart failure.

Authors:  Huanhuan Miao; Changhong Zou; Shijie Yang; Yook-Chin Chia; Minh Van Huynh; Guru Prasad Sogunuru; Jam Chin Tay; Tzung-Dau Wang; Kazuomi Kario; Yuqing Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-09       Impact factor: 2.885

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.